| ED group | | |
---|
|
no-mild
(IIEF-5: 25 − 17 points)
|
moderate-severe
(IIEF-5: 16 − 1 points)
|
p-value
|
---|
n
| 146 | 129 | |
Age (SD)
| 50.27 (13.11) | 60.64 (11.34) | < 0.001 |
BMI (SD)
| 26.18 (4.75) | 27.01 (4.07) | 0.145 |
Smoking (%)
| 24 (16.4) | 32 (24.8) | 0.117 |
OAC (%)
| 9 (20.5) | 20 (39.2) | 0.079 |
D.m. (%)
| 9 (6.2) | 18 (14.0) | 0.050 |
CVD (%)
| 40 (27.4) | 66 (51.2) | < 0.001 |
CKD (%)
| 16 (11.0) | 22 (17.1) | 0.198 |
PCa (%)
| 2 (1.4) | 6 (6.5) | 0.085 |
other Ca (%)
| 26 (17.8) | 34 (26.4) | 0.117 |
ED aids (%)
| 12 (8.6) | 31 (23.0) | 0.002 |
-
Abbreviations: ED = erectile dysfunction, IIEF-5 = international index of erectile function 5 questionnaire, SD = standard deviation, BMI = body-mass index, OAC = oral anticoagulation, D.m. = diabetes mellitus, CVD = cardiovascular disease, CKD = chronic kidney disease, PCa = prostate cancer, Ca = Cancer, ED aids = usage of oral PDE-5-inhibitor, intraurethral prostaglandin, intracavernosal prostaglandin, penile ring or penile vacuum pump (alone or in combination) in > 50% of sexual activities